Page 12 - புதுப்பிக்கப்பட்டது கட்டுமானம் உபகரணங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from புதுப்பிக்கப்பட்டது கட்டுமானம் உபகரணங்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In புதுப்பிக்கப்பட்டது கட்டுமானம் உபகரணங்கள் Today - Breaking & Trending Today

Welcome To IANS Live - SCIENCE - Google to block apps from accessing entire app list on phones

Photo Credit: IANS
IANSLive
New Delhi, April 3 (IANS) Are you aware that any single app on your smartphone can see every other app that you have installed on your device, thus accessing sensitive information like dating preferences, banking information, political affiliation and password management etc? Google has announced to change this system on its Play Store from May 5.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter. ....

New Delhi , India Private , News Service , Play Store , All Rights , புதியது டெல்ஹி , இந்தியா ப்ரைவேட் , செய்தி சேவை , விளையாடு கடை , அனைத்தும் உரிமைகள் ,

Welcome To IANS Live - SCIENCE AND TECHNOLOGY - Google Home's new settings to help customise 'Feed' tab

Through the new settings, users can customize the Feed tab to ....

San Francisco , United States , India Private , News Service , Google Home , All Rights , சான் பிரான்சிஸ்கோ , ஒன்றுபட்டது மாநிலங்களில் , இந்தியா ப்ரைவேட் , செய்தி சேவை , கூகிள் வீடு , அனைத்தும் உரிமைகள் ,

Pfizer Inc.: Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study

(0)
Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective with 91.3% vaccine efficacy observed against COVID-19, measured seven days through up to six months after the second dose
Vaccine was 100% effective in preventing severe disease as defined by the U.S. Centers for Disease Control and Prevention and 95.3% effective in preventing severe disease as defined by the U.S. Food and Drug Administration
Vaccine was 100% effective in preventing COVID-19 cases in South Africa, where the B.1.351 lineage is prevalent
Vaccine safety now evaluated in more than 44,000 participants 16 years of age and older, with more than 12,000 vaccinated participants having at least six months follow-up after their second dose ....

South Africa , United States , United Kingdom , Sylke Maas , Albert Bourla , Chuck Triano , Ugur Sahin , Fosun Pharma , Jerica Pitts , Centers For Disease , Us Centers For Disease , Drug Administration , Bayer Animal Health , Exchange Commission , Pfizer Inc , European Union , Roche Group , Vaccine Administration Under Emergency Use Authorization , Disease Control , Biologics License Application , Chief Executive Officer , Emergency Use Authorization , Coronavirus Disease , Fact Sheet , Healthcare Providers Administering Vaccine , Vaccination Providers ,

BioNTech SE: Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study

(1)
Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective with 91.3% vaccine efficacy observed against COVID-19, measured seven days through up to six months after the second dose
Vaccine was 100% effective in preventing severe disease as defined by the U.S. Centers for Disease Control and Prevention and 95.3% effective in preventing severe disease as defined by the U.S. Food and Drug Administration
Vaccine was 100% effective in preventing COVID-19 cases in South Africa, where the B.1.351 lineage is prevalent
Vaccine safety now evaluated in more than 44,000 participants 16 years of age and older, with more than 12,000 vaccinated participants having at least six months follow-up after their second dose ....

South Africa , New York , United States , United Kingdom , Sylke Maas , Albert Bourla , Chuck Triano , Ugur Sahin , Fosun Pharma , Jerica Pitts , Centers For Disease , Us Centers For Disease , Pfizer Inc Nasdaq , Drug Administration , Bayer Animal Health , Exchange Commission , European Union , Roche Group , Vaccine Administration Under Emergency Use Authorization , Disease Control , Biologics License Application , Chief Executive Officer , Marketing Authorizations Holder , Emergency Use Authorization , Adverse Events , Fact Sheet ,

Updated TVS Apache RR 310 price to be revealed soon

TVS will launch the updated for 2021 Apache RR 310 in the coming weeks. Click here to know more. ....

Tamil Nadu , Michelin Road , Tvs Apache , Rr 310 , தமிழ் நாடு , மைக்கேலின் சாலை , தொலைக்காட்சிகள் அப்பாச்சி ,